At-line Solutions for Upstream Bioprocessing - APPLICATION NOTEBOOK

Guides | 2024 | WatersInstrumentation
Sample Preparation, HPLC, LC/TOF, LC/HRMS, LC/MS, GPC/SEC
Industries
Pharma & Biopharma
Manufacturer
Waters

Importance of Topic


Modern biotherapeutic development relies on rapid, reliable, and user-friendly at-line analytical solutions to monitor both process parameters and product quality attributes. Integrating advanced LC-MS with automated sample preparation and intuitive informatics bridges the gap between core analytical laboratories and bioprocess teams, accelerating decision-making in upstream cell culture and accelerating time to clinic.

Study Objectives and Overview


This collection of application notes from Waters demonstrates end-to-end at-line solutions for upstream bioprocessing. Key goals:
  • Implement high-resolution LC-MS workflows for cell culture media nutrient and metabolite profiling
  • Monitor intact monoclonal antibodies (mAbs) and subunit product quality attributes (glycans, modifications)
  • Develop high-throughput automated sample preparation using the Andrew+ pipetting robot
  • Provide walk-up interfaces and integrated informatics (waters_connect, OneLab) for non-MS experts

Methodology and Instrumentation


Advanced technologies combined in unified workflows:
  • Liquid Chromatography–Mass Spectrometry: BioAccord™ LC-MS System with ACQUITY™ Premier columns and RDa/Tof detection for cell culture media and protein/subunit analysis
  • Automation: Andrew+™ Pipetting Robot (Extraction+ and Heater/Shaker+ modules) for automated dilution, Protein A capture, FabRICATOR digestion, glycan labeling, buffer exchange, and cleanup
  • Informatics: waters_connect™ and UNIFI™ platforms with dedicated applications (Intact Mass™, Peptide MAM, Glycan Screening) to automate data acquisition, processing, trending, and reporting
  • Integration: Sample information exchange with Sartorius Ambr® high-throughput reactors via OneLab data interface

Results and Discussion


1. Cell Culture Media Profiling:
  • Screened 200+ compounds in spent media using nine-minute LC-MS method
  • Accurate monitoring of amino acids, vitamins, nucleotides, and metabolites with multivariate data analysis (MVDA)
2. Intact mAb Monitoring:
  • Rapid 2.4-minute SEC-FLR method for direct titer and aggregate analysis in cell culture samples
  • High sensitivity with 0.05–0.5 µL sample loads and extended column lifetimes
3. Subunit and Peptide-Level Attribute Analysis:
  • High-throughput FabRICATOR digestion and LC-MS subunit screening for glycoform distribution and low-level PTMs
  • Automated RapiZyme™ trypsin digestion and focused peptide mapping to quantify site-specific modifications (oxidation, deamidation, glycation)
4. Glycan Analysis:
  • Automated GlycoWorks™ RapiFluor-MS protocol with added diafiltration for mAbs in any buffer or concentration
  • Five-minute UPLC-MS method yields reproducible high- and low-abundance glycan profiles
5. Walk-Up Solutions:
  • OneLab interface to trigger Andrew+ sample prep and BioAccord acquisition in a single walk-up workflow
  • Bioprocess engineers can generate intact mass and media data at point of need without LC-MS expertise

Benefits and Practical Applications


  • High throughput: 48-sample prep in 2–4 hours and sub-10-minute sample LC-MS runs
  • Low sample consumption: µg-level loads suitable for microbioreactors
  • Flexibility: workflows adaptable to any buffer or sample concentration
  • Data quality: high sensitivity, reproducibility, and integrated reporting templates
  • Empowerment: non-specialists can perform advanced LC-MS analytics on-site

Future Trends and Potential Applications


Continued evolution will focus on:
  • Deeper multi-attribute monitoring combining intact, subunit, peptide, and glycan mapping in a single run
  • Expanded on-board data analytics with AI-driven process insights via MVDA and predictive modeling
  • Integration with other PAT tools (online UV, Raman, HPLC) for real-time bioreactor control
  • Application to novel modalities: fusion proteins, cell and gene therapies, oligonucleotides

Conclusion


By combining robust LC-MS platforms, advanced sample preparation automation, and user-friendly informatics, Waters At-line Solutions for Upstream Bioprocessing enable rapid, reproducible, and accessible process and product attribute monitoring. These technologies empower bioprocess engineers to make data-driven decisions in real time, shortening development timelines and enhancing product quality.

References


1. Alelyunas YW et al. Cyt. J. Bioprocess Technol. 2021; 720007359EN
2. Shion H et al. Waters Application Note 720007547. 2022
3. Koza SM et al. Waters Application Note 720008042. 2023

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Multi-Attribute Methods for Biopharmaceutical Analysis
Analytical LC-MS Platform Methodologies to Support Upstream Bioprocess Optimization
Monitoring Intact Glycoprofiles and Spent Media Metabolites in Samples from Sartorius Ambr 250 High Throughput Bioreactor System to Support Upstream Process Development
Simplifying Bioreactor In-Process Monitoring with Waters Bioprocess Walk-Up Solutions